Ear Diseases D004427

Diseases [C] » Otorhinolaryngologic Diseases [C09] » Ear Diseases

Description

Pathological processes of the ear, the hearing, and the equilibrium system of the body.   MeSH

Hierarchy View

Subtype Terms (16)

Cholesteatoma, Middle Ear
 

Congenital Microtia
4 drugs (2 approved, 2 experimental)

Earache
1 approved drug

Ear Deformities, Acquired
1 approved drug

Ear Neoplasms
 

Hearing Disorders
6 drugs (3 approved, 3 experimental)

Herpes Zoster Oticus
 

Labyrinth Diseases
2 experimental drugs

Myringosclerosis
2 approved drugs

Otitis
16 drugs (12 approved, 4 experimental)

Otomycosis
8 drugs (2 approved, 6 experimental)

Otosclerosis
2 approved drugs

Ototoxicity
14 drugs (10 approved, 4 experimental)

Retrocochlear Diseases
 

Susac Syndrome
 

Tympanic Membrane Perforation
7 drugs (1 approved, 6 experimental)


Phase 2 Indicated Drugs (2)


Organization Involved with Phase 3 Indications (2)

Organization Involved with Phase 1 Indications (2)

Organization Involved with Other Experimental Indications (1)

Hierarchy Tree View

UMLS Data


YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.